|
16 Oct 2014 |
Novartis announces CTL019 data published in NEJM demonstrating efficacy in certain patients with acute lymphoblastic leukemia (ALL)
|
|
15 Oct 2014 |
Dicerna Presents Preclinical Data for Investigational RNAi Therapeutic DCR-PH1 in Primary Hyperoxaluria Type 1 (PH1) at the 10th Annual Meeting of the Oligonucleotide Therapeutics Society
|
|
15 Oct 2014 |
ACT Announces Positive Results from Two Clinical Trials Published in The Lancet Using Differentiated Stem Cell-Derived Retinal Pigment Epithelium (RPE) Cells for the Treatment of Macular Degeneration
|
|
14 Oct 2014 |
Idera Pharmaceuticals Expands Pipeline by Initiating Clinical Development of Proprietary TLR Antagonist Candidate IMO-9200
|
|
14 Oct 2014 |
Regulus Presents New Preclinical Data on Multiple Programs and Provides Portfolio Overview at 10th Annual Oligonucleotide Therapeutics Society (OTS) Meeting
|
|
14 Oct 2014 |
Alnylam Presents New Clinical and Pre-Clinical Data on RNAi Therapeutics at 10th Oligonucleotide Therapeutics Society (OTS) Meeting
|
|
14 Oct 2014 |
bluebird bio Announces First Patient with Sickle Cell Disease Transplanted with LentiGlobin Gene Therapy
|
|
14 Oct 2014 |
Rigontec GmbH Raises €9.45m in a First Closing of a Series A Financing Round to Advance RNA-based Immunotherapeutics for Cancer and Viral Diseases
|
|
14 Oct 2014 |
MOLOGEN AG presents EnanDIM: A new generation of immunomodulators
|
